Stay updated on Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. This is an internal versioning change and does not affect user-facing content.
    Difference
    0.1%
    Check dated 2026-03-12T01:05:26.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the lapse notice about government funding and the related Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:25:58.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding notice about the NIH Clinical Center status and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:27:18.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated status labels to 'Last Update Submitted that Met QC Criteria' with a 'No FEAR Act Data' indicator and revision 'v3.4.0'. The previous wording 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' term, and revision 'v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:07:27.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The site revision was updated from v3.3.3 to v3.3.4, a minor UI/metadata update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:16:11.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:12:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.